- by Priyanka RunwalThe US won’t be party to the global agreement that will allow for rapid sharing of pandemic-related information, pathogen samples, and genetic sequences
- by Laurel OldachDrugmakers sort through many modalities to find the best match for their target proteins
- by Sarah BranerNew methods may unravel molecular mysteries of α-1-antitrypsin deficiency
- by Prachi PatelDevices can record neural activity for hours, then be peeled off without damaging hair
- by Monika Mondal, special to C&ENThe epigenetic mark 4mC was previously unknown in plants
- by Aayushi PratapCime Therapeutics focuses on synthesizing compounds for targets implicated in cancers
- by Max BarnhartEven de-extinction advocates say that Colossal Biosciences’ claims are misleading
- by Sarah BranerPretzel Therapeutics’ polymerase stabilizers could treat mitochondrial DNA-based diseases
- by Alex ScottRacers are looking for an edge with hemoglobin boosts and glycolysis acceleration
- by Alex ScottRacers are looking for an edge with hemoglobin boosts and glycolysis acceleration
Making chemistry accessible and relevant.